Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network

Authors:

Abstract
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes1 and is the leading cause of new cases of blindness among adults 20 to 74 years of age in the United States.2 By 2050, the prevalence of DR in patients 40 years of age or older with type 1 or 2 diabetes is projected to increase to 16.0 million (from 5.5 million in 2005), and the prevalence of vision-threatening DR is projected to increase to 3.4 million (from 1.2 million in 2005).3

This publication has 42 references indexed in Scilit: